Using proteomics for stratification and risk prediction in patients with solid tumors.

Area of Science:

• Proteomics and its role in understanding cellular biology and disease.
• Integration of analytical chemistry and computational biology in life sciences.

Background:

• Proteomics captures dynamic protein expression and interactions, crucial for understanding cellular processes.
• Genomic and transcriptomic data alone often fail to reflect the complexity of cancer biology.
• Proteins are key players in cellular functions, making their study vital for disease research.

Purpose of the Study:

• To highlight the evolution and significance of proteomics in biological and clinical research.
• To demonstrate the application of proteomics in understanding cancer and improving patient care.
• To emphasize the role of advanced technologies like LC-MS in proteomic analysis.

Main Methods:

• Utilizing liquid chromatography-mass spectrometry (LC-MS) for high-throughput proteomic data generation.
• Employing computational biostatistics, including R tools, for analyzing complex proteomic datasets.
• Integrating proteomics with genomics to overcome limitations and enhance peptide identification.

Main Results:

• Proteomic analysis reveals protein expression patterns and correlations with clinical variables.
• Case studies in intrahepatic cholangiocarcinoma, glioblastoma, and pancreatic cancer showcase clinical applications.
• Proteomics aids in cancer subtyping, diagnostic marker identification, and understanding pathway activities.

Conclusions:

• Proteomics provides critical insights into cellular biology and disease mechanisms, particularly cancer.
• The integration of proteomics with other omics and clinical data enhances personalized medicine approaches.
• Advanced proteomic techniques are essential for advancing our understanding of biological systems and improving clinical outcomes.